Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

The oral Janus kinase (JAK) inhibitor baricitinib has demonstrated efficacy in inducing and maintaining glucocorticoid-free remission in patients with early polymyalgia rheumatica, according to the phase 3 JAK-Spare trial.

Baricitinib a promising steroid-sparing option in early polymyalgia rheumatica

Continuous vs bolus infusion of terlipressin: Which works best in acute variceal haemorrhage?

Administration of terlipressin as either continuous or bolus infusion results in similar length of hospital stay, packed cell volume, rebleeding, and mortality rates in patients with acute variceal haemorrhage, a recent study has shown.

Continuous vs bolus infusion of terlipressin: Which works best in acute variceal haemorrhage?

Buprenorphine extends antisuicide effect of ketamine in MDD

The use of buprenorphine helps prolong the antisuicidal benefits derived from treatment with ketamine in patients with major depressive disorder (MDD), suggests a study.

Buprenorphine extends antisuicide effect of ketamine in MDD

26 Jun 2026

SCB holds slight edge over PCB for PAD in SIRONA trial

The 3-year results from the SIRONA trial demonstrate the superiority of a sirolimus-coated balloon (SCB) over a paclitaxel-coated balloon (PCB) in terms of freedom from clinically driven target lesion revascularization (TLR) in patients with symptomatic femoropopliteal artery disease.

SCB holds slight edge over PCB for PAD in SIRONA trial

26 Jun 2026

Novel GLP-1 RA for weight management clears phase 2 study

The investigational oral small-molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA) elecoglipron yields meaningful weight reductions with a safety profile consistent with the drug class, according to a phase 2 dose-ranging study.

Novel GLP-1 RA for weight management clears phase 2 study

PCV15 prevents AOM in children

The V114-032 trial, presented at ESPID 2026, shows that administering the 15-valent pneumococcal conjugate vaccine (PCV15) reduces the incidence of first vaccine-type acute otitis media (VT-AOM) among healthy children.

PCV15 prevents AOM in children

Topical chlorhexidine 1% reduces maternal, neonatal bacterial colonization

Topical application of chlorhexidine 1% proves effective at reducing bacterial load in both mothers and neonates, according to the results of a randomized controlled trial.

Topical chlorhexidine 1% reduces maternal, neonatal bacterial colonization

Oral probiotic supplementation may lower risk of preterm delivery recurrence

25 Jun 2026 bởi

Oral supplementation with probiotics containing Clostridium species may protect against the recurrence of spontaneous preterm delivery in high-risk pregnant women, according to a prospective, single-arm, trial conducted in Japan.

Oral probiotic supplementation may lower risk of preterm delivery recurrence

Opioid systems influence ketamine’s antidepressant effect

Complex interactions between glutamatergic, opioidergic, and GABAergic systems modulate the antidepressant effects of ketamine on cerebral blood flow (CBF) in patients with major depressive disorder (MDD), suggests a recent study.

Opioid systems influence ketamine’s antidepressant effect

Letermovir safe to use for CMV prevention in paediatric HSCT recipients

25 Jun 2026 bởi

Real-life use of letermovir in paediatric recipients of haematopoietic stem cell transplant (HSCT) is generally safe and prevents the development of cytomegalovirus (CMV) disease, as shown in a study presented at ESPID 2026.

Letermovir safe to use for CMV prevention in paediatric HSCT recipients